Abstract:Zoonotic hepatitis E virus (HEV) infection is an emerging global public health concern. It is usually transmitted to humans from domestic pigs (main host). Since virus-like particles (VLPs) exhibit unique structural and immunological characteristics that make them of momentous applications in vaccine development, the purpose of the present study was the production of immunogenic chimeric VLPs as vaccine candidates for the control of zoonotic HEV in its main host and the prevention of porcine circovirus associated disease, a multi-factorial disease with major economic repercussions on global pig industry. An immuno-informatics approach was applied for the design and screening of new chimeric antigens presenting the dominant immunogenic domains of both HEV and porcine circovirus 2 (PCV2). Then, using molecular cloning techniques, the chimeric proteins were expressed in Escherichia coli. After purification, full characterization of the physicochemical, morphological, and immunological properties of the target proteins has been conducted. The chimeric immunogens were successfully overexpressed and after the optimization of the expression conditions, 5 chimeric proteins were efficiently purified under native conditions. The purified HEV-PCV2 chimeric proteins were found thermo-stable and able to self-assemble into spherical virus-like particles. Four HEV-PCV2 chimeric proteins have displayed optimal antigenicity and immunogenicity properties, with the nPCV2cp-p166 chimeric immunogen slightly outranking the other designed proteins. In conclusion, this study reports the production of stable HEV-PCV2 chimeric VLPs that exhibited optimal antigenicity and immunogenicity and thus with potential applications in diagnostics and vaccine development. Besides, this study provides a reproducible approach for the design, assessment, and production of chimeric antigens.

A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles

Plant-Produced Chimeric Hepatitis E Virus-like Particles as Carriers for Antigen Presentation

Challenges in Creating A Vaccine to Prevent Hepatitis E

Rapid High-Yield Transient Expression of Swine Hepatitis E ORF2 Capsid Proteins in Nicotiana benthamiana Plants and Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope

High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors

Expression of Orf2 Partial Gene of Hepatitis E Virus in Tomatoes and Immunoactivity of Expression Products

[Expression, Purification and Immunogenicity of a Novel Hepatitis E Virus-Like Particle].

Expression and Self-Assembly of Empty Virus-Like Particles of Hepatitis E Virus

Expression and Characterization of Hepatitis E Virus-Like Particles and Non-Virus-like Particles from Insect Cells.

Expression and Characterization of A Recombinant Truncated Capsid Protein of Hepatitis E Virus in Pichia Pastoris

[Fermentation, Purification and Immunogenicity Evaluation of Hepatitis E Virus-Like Particles Expressed in Hansenula Polymorpha].

Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice

Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli

Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).

[Expression,purification,structure Determination and Immunogenicity Assay of Hepatitis E Virus Capsid Protein P495 Derived from Baculovirus-based Insect Cell].

Characterization of Capsid Protein (p495) of Hepatitis E Virus Expressed in Escherichia Coli and Assembling into Particles in Vitro.

Production of Hepatitis E Virus-Like Particles Presenting Multiple Foreign Epitopes by Co-Infection of Recombinant Baculoviruses.

Efficient Production and Characterization of Immunogenic HEV-PCV2 Chimeric Virus-Like Particles

Immunogenicity and Efficacy of a Bacterially Expressed HEV ORF3 Peptide, Assessed by Experimental Infection of Primates.

Establishment of a Plasmid-Based Reverse Genetics System for the Cell Culture-Adapted Hepatitis E Virus Genotype 3c Strain 47832c

Preparation and Immune Effect of HEV ORF2 P206@PLGA Nanoparticles